Articles with "hypertrophy" as a keyword



Photo from wikipedia

Protective effect of histone methyltransferase NSD3 on ISO‐induced cardiac hypertrophy

Sign Up to like & get
recommendations!
Published in 2019 at "FEBS Letters"

DOI: 10.1002/1873-3468.13515

Abstract: Nuclear receptor‐binding SET domain 3 (NSD3) is a lysine methyltransferase that plays important roles in multiple biological activities; however; its potential roles in the cardiovascular system remain unknown. In this study, we found that NSD3… read more here.

Keywords: cardiomyocyte hypertrophy; protective effect; methyltransferase; hypertrophy ... See more keywords
Photo from wikipedia

Genome‐wide analysis of the mouse LIM gene family reveals its roles in regulating pathological cardiac hypertrophy

Sign Up to like & get
recommendations!
Published in 2021 at "FEBS Letters"

DOI: 10.1002/1873-3468.14168

Abstract: LIM‐domain proteins have been shown to be associated with heart development and diseases. Systematic studies of LIM family members at the genome‐wide level, which are crucial to further understand their functions in cardiac hypertrophy, are… read more here.

Keywords: genome wide; cardiac hypertrophy; analysis mouse; family ... See more keywords
Photo from wikipedia

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB-C/EBPβ Axis.

Sign Up to like & get
recommendations!
Published in 2023 at "Advanced science"

DOI: 10.1002/advs.202300585

Abstract: Inhibition of pathological cardiac hypertrophy is recognized as an important therapeutic strategy for heart failure, although effective targets are still lacking in clinical practice. Homeodomain interacting protein kinase 1 (HIPK1) is a conserved serine/threonine kinase… read more here.

Keywords: pathological cardiac; hypertrophy; hipk1; cardiac hypertrophy ... See more keywords
Photo from wikipedia

Chrysophanol attenuated isoproterenol‐induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway

Sign Up to like & get
recommendations!
Published in 2019 at "Cell Biology International"

DOI: 10.1002/cbin.11146

Abstract: Cardiac hypertrophy is a common pathological change found in various cardiovascular diseases. Although it has long been recognized as an important risk factor responsible for heart failure, there is still a lack of effective treatments… read more here.

Keywords: cardiac hypertrophy; transcription; induced cardiac; hypertrophy ... See more keywords
Photo from wikipedia

Inhibition of intermittent calcium‐activated potassium channel (SK4) attenuates Ang II‐induced hypertrophy of human‐induced stem cell‐derived cardiomyocytes via targeting Ras–Raf–MEK1/2–ERK1/2 and CN–NFAT signaling pathways

Sign Up to like & get
recommendations!
Published in 2022 at "Cell Biology International"

DOI: 10.1002/cbin.11948

Abstract: Cardiac hypertrophy caused by angiotensin II (Ang II) is essential for the pathological process of heart failure. The intermediate calcium‐activated potassium channel (SK4) has been shown to be involved in the process of the inflammatory… read more here.

Keywords: cell; hypertrophy; cardiac hypertrophy; calcium activated ... See more keywords
Photo by nci from unsplash

Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15‐year prospective study

Sign Up to like & get
recommendations!
Published in 2020 at "Clinical Cardiology"

DOI: 10.1002/clc.23402

Abstract: Electrocardiography is the first‐choice technique for detecting left ventricular hypertrophy in patients with arterial hypertension. It is necessary to know the probable outcome for every patient during the treatment, with the aim of improving cardiovascular… read more here.

Keywords: significance hypertensive; criteria best; hypertrophy; best prognostic ... See more keywords
Photo by nci from unsplash

Prostaglandin E2 induced cardiac hypertrophy through EP2 receptor‐dependent activation of β‐catenin in 5/6 nephrectomy rats

Sign Up to like & get
recommendations!
Published in 2021 at "ESC Heart Failure"

DOI: 10.1002/ehf2.13269

Abstract: Prostaglandin E2 (PGE2) is involved in the development of cardiac hypertrophy. However, whether PGE2 regulates the chronic kidney disease‐associated cardiac hypertrophy and the tentative mechanism remains to be elucidated. read more here.

Keywords: cardiac hypertrophy; induced cardiac; hypertrophy ep2; hypertrophy ... See more keywords
Photo by jellybee from unsplash

Antioxidant and anti‐inflammatory effects of the monocarbonyl curcumin analogs B2BRBC and C66 in monocrotaline‐induced right ventricular hypertrophy

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Biochemical and Molecular Toxicology"

DOI: 10.1002/jbt.22353

Abstract: For 22 days after monocrotaline injection two groups of rats received either of the monocarbonyl curcumin analogs (2E,6E)‐2,6‐bis(2‐bromobenzylidene)cycloxehanone (B2BrBC) and (2E,6E)‐2,6‐bis([2‐trifluoromethyl]benzylidene)cyclohexanone (C66), and their right ventricle parameters were compared to those from the control and… read more here.

Keywords: monocrotaline; curcumin analogs; b2brbc c66; monocarbonyl curcumin ... See more keywords
Photo from wikipedia

Neferine attenuates doxorubicin‐induced fibrosis and hypertrophy in H9c2 cells

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Biochemical and Molecular Toxicology"

DOI: 10.1002/jbt.23054

Abstract: Doxorubicin (DOX), an anthracycline antineoplastic candidate is used to treat various malignancies. Around 41% of patients undergoing DOX treatment develop acute cardiotoxicity. Preventing DOX‐induced cardiac fibrosis and hypertrophy helps in evading cardiac remodeling leading to… read more here.

Keywords: hypertrophy; fibrosis hypertrophy; dox; h9c2 ... See more keywords
Photo from wikipedia

Tropisetron restores normal expression of BAD, SIRT1, SIRT3, and SIRT7 in the rat pressure overload-induced cardiac hypertrophy model.

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of biochemical and molecular toxicology"

DOI: 10.1002/jbt.23355

Abstract: Tropisetron exerts a protective effect against cardiac complications, particularly cardiac hypertrophy. Oxidative stress and apoptosis are the main contributors to the pathogenesis of cardiac hypertrophy. Sirtuins, a family of histone deacetylases, are connected to cellular… read more here.

Keywords: hypertrophy; sirt1 sirt3; expression; cardiac hypertrophy ... See more keywords
Photo from wikipedia

Glycosylated CD147 reduces myocardial collagen cross‐linking in cardiac hypertrophy

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Cellular Biochemistry"

DOI: 10.1002/jcb.26713

Abstract: The mechanism of transition from chronic pressure overload‐induced cardiac hypertrophy to heart failure is still unclear. Angiotensin II (Ang II) may be an important factor that mediates the transition in the end‐stage of cardiac hypertrophy.… read more here.

Keywords: cardiac hypertrophy; hypertrophy; cross linking; collagen cross ... See more keywords